BioVie Inc. Income (Loss) Attributable to Parent, before Tax
BioVie Inc. (BIVI) reported Income (Loss) Attributable to Parent, before Tax of -$22.12 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2026-08-13
- BioVie Inc. income (loss) attributable to parent, before tax for the quarter ending 2026-06-30 was -$5.65M.
- BioVie Inc. income (loss) attributable to parent, before tax for the quarter ending 2026-03-31 was -$5.27M.
- BioVie Inc. income (loss) attributable to parent, before tax for the quarter ending 2025-12-31 was -$6.07M.
- BioVie Inc. income (loss) attributable to parent, before tax for the quarter ending 2025-09-30 was -$5.13M.
- BioVie Inc. income (loss) attributable to parent, before tax for fiscal 2026 was -$22.12M.
- BioVie Inc. income (loss) attributable to parent, before tax for fiscal 2025 was -$17.91M.
- BioVie Inc. income (loss) attributable to parent, before tax for fiscal 2023 was -$50.26M.
- BioVie Inc. income (loss) attributable to parent, before tax for fiscal 2022 was -$26.08M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 3 month as first filed | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month | Income (Loss) Attributable to Parent, before Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$5.65M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | -$10.92M derived: sum of 2 quarters · filed 2026-08-13 | -$16.99M derived: sum of 3 quarters · filed 2026-08-13 | -$22.12M 10-K · filed 2026-08-13 | |
| 2026-03-31 | -$5.27M S-1/A · filed 2026-08-06 | -$11.34M derived: sum of 2 quarters · filed 2026-08-06 | -$16.47M S-1/A · filed 2026-08-06 | -$19.96M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$6.07M 10-Q · filed 2026-02-06 | -$11.20M 10-Q · filed 2026-02-06 | -$14.69M derived: sum of 3 quarters · filed 2026-08-13 | -$17.48M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$5.13M 10-Q · filed 2025-11-10 | -$8.62M derived: sum of 2 quarters · filed 2026-08-13 | -$11.41M derived: sum of 3 quarters · filed 2026-08-13 | -$18.57M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$3.49M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | -$6.28M derived: sum of 2 quarters · filed 2026-08-13 | -$13.43M derived: sum of 3 quarters · filed 2026-08-13 | -$17.91M 10-K · filed 2026-08-13 | |
| 2025-03-31 | -$2.79M S-1/A · filed 2026-08-06 | -$9.95M derived: sum of 2 quarters · filed 2026-08-06 | -$14.42M S-1/A · filed 2026-08-06 | -$19.36M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | -$7.16M 10-Q · filed 2026-02-06 | -$11.63M 10-Q · filed 2026-02-06 | -$16.57M derived: sum of 3 quarters · filed 2026-08-06 | -$25.53M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-09-30 | -$4.48M 10-Q · filed 2025-11-10 | -$9.42M derived: sum of 2 quarters · filed 2026-08-06 | -$18.37M derived: sum of 3 quarters · filed 2026-08-06 | -$26.77M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-06-30 | -$4.94M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | -$13.90M derived: sum of 2 quarters · filed 2026-08-06 | -$22.30M derived: sum of 3 quarters · filed 2026-08-06 | -$33.01M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | -$8.95M 10-Q · filed 2025-05-12 | -$17.36M derived: sum of 2 quarters · filed 2025-05-12 | -$28.07M 10-Q · filed 2025-05-12 | -$37.18M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$8.40M 10-Q · filed 2025-02-11 | -$19.11M 10-Q · filed 2025-02-11 | -$28.22M derived: sum of 3 quarters · filed 2025-02-11 | -$43.27M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-09-30 | -$10.71M 10-Q · filed 2024-11-13 | -$19.82M derived: sum of 2 quarters · filed 2024-11-13 | -$34.86M derived: sum of 3 quarters · filed 2024-11-13 | -$50.55M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$24.15M derived: sum of 2 quarters · filed 2024-09-30 | -$39.84M derived: sum of 3 quarters · filed 2024-09-30 | -$50.26M 10-K · filed 2024-09-30 | |
| 2023-03-31 | -$15.04M 10-Q · filed 2024-05-14 | -$30.73M derived: sum of 2 quarters · filed 2024-05-14 | -$41.14M 10-Q · filed 2024-05-14 | -$49.23M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$15.69M 10-Q · filed 2024-02-13 | -$26.10M 10-Q · filed 2024-02-13 | -$34.19M derived: sum of 3 quarters · filed 2024-02-13 | -$41.23M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | -$10.42M 10-Q · filed 2023-11-08 | -$18.50M derived: sum of 2 quarters · filed 2023-11-08 | -$25.55M derived: sum of 3 quarters · filed 2023-11-08 | -$30.96M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | -$15.13M derived: sum of 2 quarters · filed 2023-08-16 | -$20.54M derived: sum of 3 quarters · filed 2023-08-16 | -$26.08M 10-K · filed 2023-08-16 | |
| 2022-03-31 | -$7.04M 10-Q · filed 2023-05-12 | -$12.45M derived: sum of 2 quarters · filed 2023-05-12 | -$18.00M 10-Q · filed 2023-05-12 | -$149.53M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$5.41M 10-Q · filed 2023-02-10 | -$10.96M 10-Q · filed 2023-02-10 | -$142.49M derived: sum of 3 quarters · filed 2023-02-10 | -$145.48M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | -$5.54M 10-Q · filed 2022-11-04 | -$137.07M derived: sum of 2 quarters · filed 2022-11-04 | -$140.07M derived: sum of 3 quarters · filed 2022-11-04 | -$143.12M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | -$131.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$134.53M derived: sum of 2 quarters · filed 2022-09-27 | -$137.58M derived: sum of 3 quarters · filed 2022-09-27 | -$183.85M 10-K · filed 2022-09-27 | |
| 2021-03-31 | -$2.99M 10-Q · filed 2022-05-11 | -$6.05M derived: sum of 2 quarters · filed 2022-05-11 | -$52.32M 10-Q · filed 2022-05-11 | -$71.47M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | -$3.06M 10-Q · filed 2022-02-08 | -$49.32M 10-Q · filed 2022-02-08 | -$68.48M derived: sum of 3 quarters · filed 2022-02-08 | -$68.84M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-09-30 | -$46.26M 10-Q · filed 2021-11-10 | -$65.42M derived: sum of 2 quarters · filed 2021-11-10 | -$65.78M derived: sum of 3 quarters · filed 2021-11-10 | -$59.12M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$19.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | -$19.52M derived: sum of 2 quarters · filed 2021-08-30 | -$12.86M derived: sum of 3 quarters · filed 2021-08-30 | -$33.78M 10-K · filed 2021-08-30 | |
| 2020-03-31 | -$366.40K 10-Q · filed 2021-05-10 | $6.30M derived: sum of 2 quarters · filed 2021-05-10 | -$14.62M 10-Q · filed 2021-05-10 | -$15.28M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $6.67M 10-Q · filed 2021-01-29 | -$14.26M 10-Q · filed 2021-01-29 | -$14.91M derived: sum of 3 quarters · filed 2021-01-29 | -$15.76M derived: sum of 4 quarters · filed 2021-01-29 | |
| 2019-09-30 | -$20.92M 10-Q · filed 2020-11-05 | -$21.58M derived: sum of 2 quarters · filed 2020-11-05 | -$22.42M derived: sum of 3 quarters · filed 2020-11-05 | -$22.92M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$655.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | -$1.50M derived: sum of 2 quarters · filed 2020-08-07 | -$2.00M derived: sum of 3 quarters · filed 2020-08-07 | -$2.49M 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | -$848.04K 10-Q · filed 2020-05-13 | -$1.35M derived: sum of 2 quarters · filed 2020-05-13 | -$1.84M 10-Q · filed 2020-05-13 | -$2.41M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$500.51K 10-Q · filed 2020-02-13 | -$989.04K 10-Q · filed 2020-02-13 | -$1.57M derived: sum of 3 quarters · filed 2020-02-13 | -$2.26M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | -$488.53K 10-Q · filed 2019-11-19 | -$488.53K 10-Q · filed 2018-11-14 | -$1.06M derived: sum of 2 quarters · filed 2019-11-19 | -$1.76M derived: sum of 3 quarters · filed 2019-11-19 | -$2.26M derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | -$576.04K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | -$1.27M derived: sum of 2 quarters · filed 2019-09-27 | -$1.77M derived: sum of 3 quarters · filed 2019-09-27 | -$2.43M 10-K · filed 2019-09-27 | |
| 2018-03-31 | -$692.56K 10-Q · filed 2019-05-10 | -$1.20M derived: sum of 2 quarters · filed 2019-05-10 | -$1.86M 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | -$502.68K 10-Q · filed 2019-02-12 | -$1.17M 10-Q · filed 2019-02-12 | |||
| 2017-09-30 | -$662.84K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |